Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06185686
Other study ID # 202312104
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 30, 2024
Est. completion date June 30, 2027

Study information

Verified date May 2024
Source Washington University School of Medicine
Contact Stephanie Perkins, M.D.
Phone 314-747-4405
Email sperkins@wustl.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

With modern therapy, the survival rate for pediatric brain tumor patients has significantly improved, with over 70% of patients surviving their disease. However, this progress often comes at the cost of substantial morbidity, with cognitive deficits being the primary obstacle to independent living. Robust predictors of cognitive decline and a comprehensive understanding of the underlying mechanisms of cognitive injury remain elusive. This study will prospectively investigate alterations in brain resting state networks following radiation therapy using functional imaging. The hypothesis is that radiation therapy leads to dose-dependent alterations in functional connectivity in the networks associated with higher level cognition, ultimately leading to cognitive decline.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 16
Est. completion date June 30, 2027
Est. primary completion date June 30, 2027
Accepts healthy volunteers No
Gender All
Age group 8 Years to 21 Years
Eligibility Inclusion Criteria: - Between 8 and 21 years of age, inclusive - Newly diagnosed primary brain tumor of any location and any histology that will be treated with proton radiation therapy - Life expectancy of at least one year - Able to understand and willing to consent or assent to the research proposed (or that of a legally authorized representative, if applicable), along with consent of legal guardian(s) if applicable Exclusion Criteria: - Presence of visual impairment to an extent that the patient is unable to complete the computer testing - Contraindication to MRI scan (i.e. due to cardiac pacemaker) - Presence of programmable shunt or dental braces - Requires sedation for MRI scans

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cognitive testing
NIH Toolbox Cognitive Battery and the Novel Cognitive Measure (NCM)
Device:
Resting State MRI/Precision functional mapping
At baseline (before the end of radiation therapy) and approximately 12 months after the completion of radiation therapy.

Locations

Country Name City State
United States Washington University School of Medicine/Saint Louis Children's Hospital Saint Louis Missouri

Sponsors (3)

Lead Sponsor Collaborator
Washington University School of Medicine The Foundation for Barnes-Jewish Hospital, United States Department of Defense

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Radiation induced effects on functional brain resting state connectivity The investigators will compare resting state maps of each patient pre- and post-radiation therapy. The investigators will evaluate changes in the resting state architecture and compare to the average results that would be expected from a patient in the same age and sex. Through 1 year follow-up
Primary Baseline characteristics of functional network architecture The investigators will assess the unique architecture of brain networks at diagnosis and how significantly this architecture diverges from average healthy controls. At baseline (day 1)
Primary Change in characteristics of functional network architecture The investigators will assess brain system segregation which is measure of the connection and disconnection between different brain networks. These will be compared within individuals and compared to healthy controls. Baseline and 1 year follow-up
Secondary Correlation of radiation dose to changes in cognitive performance and resting state network connectivity In an exploratory fashion, the investigators will evaluate the dose of radiation received to each resting state network to determine if functional connectivity changes in a dose dependent manner at 1 year. At 1 year follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT06057168 - Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas Phase 3
Recruiting NCT04427384 - Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Completed NCT03323450 - Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working Memory N/A
Completed NCT00241670 - Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid Phase 3
Completed NCT02599142 - Comparing Immobilisation Shells in Cranial Radiotherapy N/A
Not yet recruiting NCT01445691 - More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery Phase 2
Recruiting NCT06282562 - FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients N/A
Recruiting NCT06322342 - Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent Phase 2
Completed NCT00001574 - A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors
Completed NCT04365647 - Intra-operative Variation in Size of Brain Tumors After Craniotomy
Withdrawn NCT04776980 - Multimodality MRI and Liquid Biopsy in GBM Early Phase 1
Completed NCT03262636 - Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow) Phase 1
Active, not recruiting NCT02006407 - A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain Tumors N/A
Recruiting NCT03213002 - Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM Phase 1/Phase 2
Recruiting NCT05775458 - Glutamate Excitotoxicity and Its Role in Glioblastoma Biology
Terminated NCT04901806 - Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors Phase 1
Recruiting NCT03373487 - Cognitive Rehabilitation in Brain Tumor Patients After Neurosurgery N/A
Not yet recruiting NCT06106997 - Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow N/A
Recruiting NCT05254197 - SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)
Recruiting NCT05092802 - The Efficacy of HLX208 (BRAF V600E Inhibitor) for Refractory Primary Brain Tumors With BRAF Mutation After First-line Treatment Phase 2